StonvexLoading…
StonvexStonvexStonvexCore line items from IBM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $15.92B | $67.53B | $47.85B | $31.52B |
Operating Income | $1.39B | $10.33B | $6.18B | $3.75B |
Net Income | $1.22B | $10.59B | $4.99B | $3.25B |
EPS (Diluted) | $1.28 | $11.17 | $5.27 | $3.43 |
Total Assets | $156.23B | $151.88B | $146.31B | $148.59B |
Total Liabilities | $123.17B | $119.14B | $118.32B | $121.00B |
Cash & Equivalents | $10.82B | $13.59B | $11.57B | $11.94B |
Free Cash Flow OCF − CapEx | $4.94B | $12.10B | $8.44B | $5.62B |
Shares Outstanding | 952.13M | 936.95M | 947.42M | 946.67M |